Biolevate is a France-based AI life sciences company with an AI platform that helps biomedical researchers and scientific teams turn complex experimental data, documents, and unstructured content into structured knowledge. The platform supports life science innovation by automating data extraction, document analysis, regulatory compliance checks, and literature synthesis, enabling teams to focus on discovery and insight rather than manual processing.
Founded in 2024 and backed by EQT Ventures and other investors, Biolevate’s technology empowers research and development teams across pharmaceutical, biotech, and academic sectors with advanced tools that accelerate workflows, automate scientific writing tasks, and enhance compliance and regulatory documentation efforts.